EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Acetylation of SAMHD1 at lysine 580 is crucial for blocking HIV-1 infection

Angel Bulnes-Ramos, Kerstin Schott, Jesse Rabinowitz, Charlotte Luchsinger, Cinzia Bertelli, Eri Miyagi, Corey H Yu, Mirjana Persaud, Caitlin Shepard, Renate König iD, Baek Kim, Dmitri N Ivanov und 2 weitere

mBio · 2024

DOI: 10.1128/mbio.01958-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2024. Verfasst von Angel Bulnes-Ramos und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA. Hauptthemen laut MEDLINE: SAM Domain and HD Domain-Containing Protein 1, HIV-1, Macrophages, Lysine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, HHS | NIH | National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In humans, sterile alpha motif (SAM) domain- and histidine–aspartic acid (HD) domain-containing protein 1 (SAMHD1) is a dNTPase enzyme that prevents HIV-1 infection in non-cycling cells, such as differentiated THP-1 cells and human primary macrophages. Although phosphorylation of threonine 592 (T592) in SAMHD1 is recognized as the primary regulator of the ability to prevent HIV-1 infection, the contributions of SAMHD1 acetylation to this ability remain unknown. Mass spectrometry analysis of SAMHD1 proteins derived from cycling and non-cycling THP-1 cells, primary cycling B cells, and primary macrophages revealed that SAMHD1 is preferentially acetylated at lysine residues 354, 494, and 580 (K354, K494, and K580). In non-cycling cells, SAMHD1 is preferentially acetylated at K580, suggesting that this post-translational modification may contribute to the ability of SAMHD1 to block HIV-1 infection. Consistent with this finding, we found that mutations in K580 disrupted the ability of SAMHD1 to block HIV-1 infection without affecting the ability of SAMHD1 to deplete cellular dNTP levels. Gene editing of SAMHD1 in macrophage-like cells revealed that an intact K580 is required for HIV-1 restriction. This finding suggests that K580 acetylation in SAMHD1 is essential for blocking HIV-1 infection. More importantly, we found that a larger proportion of SAMHD1 featuring K580 acetylation could be detected in human primary macrophages when compared to human primary monocytes. In agreement, we found that SAMHD1 is acetylated during the monocyte-to-macrophage differentiation process. This finding agrees with the idea that the blockade of HIV-1 infection in macrophages requires SAMHD1 acetylation. IMPORTANCE The natural inhibitor of HIV-1, sterile alpha motif (SAM) domain- and histidine–aspartic acid (HD) domain-containing protein 1 (SAMHD1), plays a pivotal role in preventing HIV-1 infection of macrophages and dendritic cells, which are vital components of the immune system. This study unveils that SAMHD1 undergoes post-translational modifications, specifically acetylation at lysines 354, 494, and 580. Our research underscores the significance of these modifications, demonstrating that acetylation at residue K580 is indispensable for SAMHD1's efficacy in blocking HIV-1 infection. Notably, K580 is found in a critical regulatory domain of SAMHD1, highlighting acetylation as a novel layer of SAMHD1 regulation for HIV-1 restriction in humans. A comprehensive understanding of the regulation mechanisms governing this anti-HIV-1 protein is crucial for leveraging nature's defense mechanisms against HIV-1 and could pave the way for innovative therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SAM Domain and HD Domain-Containing Protein 1HIV-1MacrophagesLysineProtein Processing, Post-TranslationalHIV InfectionsHumansAcetylationTHP-1 CellsB-Lymphocytes

Stichwörter der Autor:innen

HIV-1K580SAMHD1acetylationinnate immunitymacrophagesrestriction

Substanzen

SAM Domain and HD Domain-Containing Protein 1SAMHD1 protein, humanLysine

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA.
  • Host-Pathogen Interactions, Paul-Ehrlich-Institute, Langen, Germany.
  • Viral Biochemistry Section NIAID, NIH, Bethesda, Maryland, USA.
  • Department of Biochemistry, UTHSA, San Antonio, Texas, USA.
  • Department of Pediatrics, Center for ViroScience and Cure, School of Medicine, Emory University, Atlanta, Georgia, USA.
  • Children's Healthcare of Atlanta, Atlanta, Georgia, USA.

ORCID-Profile: Renate König, Felipe Diaz-Griffero

Förderung

  • NIAID NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases

Zitieren

APA

Bulnes-Ramos, A., Schott, K., Rabinowitz, J., Luchsinger, C., Bertelli, C., Miyagi, E., Yu, C. H., Persaud, M., Shepard, C., König, R., Kim, B., Ivanov, D. N., Strebel, K., & Diaz-Griffero, F. (2024). Acetylation of SAMHD1 at lysine 580 is crucial for blocking HIV-1 infection. mBio. https://doi.org/10.1128/mbio.01958-24

Vancouver

Bulnes-Ramos A, Schott K, Rabinowitz J, Luchsinger C, Bertelli C, Miyagi E, et al. Acetylation of SAMHD1 at lysine 580 is crucial for blocking HIV-1 infection. mBio. 2024. doi:10.1128/mbio.01958-24

BibTeX
@article{BulnesRamos2024,
  author = {Bulnes-Ramos, Angel and Schott, Kerstin and Rabinowitz, Jesse and Luchsinger, Charlotte and Bertelli, Cinzia and Miyagi, Eri and Yu, Corey H and Persaud, Mirjana and Shepard, Caitlin and König, Renate and Kim, Baek and Ivanov, Dmitri N and Strebel, Klaus and Diaz-Griffero, Felipe},
  title = {Acetylation of SAMHD1 at lysine 580 is crucial for blocking HIV-1 infection},
  journal = {mBio},
  year = {2024},
  doi = {10.1128/mbio.01958-24}
}
Kostenlos starten →